SCHEMBL9200532

SCHEMBL9200532

CC1(C)COC1(Cn1cncn1)c1ccc(F)cc1F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 10/20 0.42
CYP2C9 P11712 8/20 0.42
CYP2C19 P33261 6/20 0.42
CYP19A1 P11511 5/20 0.42
CYP11B1 P15538 2/20 0.42
CYP11B2 P19099 2/20 0.42
LMNA P02545 2/20 0.42
HSP90AA1 P07900 1/20 0.42
ADRA1A P35348 1/20 0.42
CYP51A1 Q16850 1/20 0.42
CYP1A2 P05177 4/20 0.40
CYP2D6 P10635 3/20 0.40
THRB P10828 1/20 0.39
ABCB11 O95342 1/20 0.38
CYP17A1 P05093 1/20 0.38
PTGS2 P35354 1/20 0.38
ABCG2 Q9UNQ0 1/20 0.38
CYP8B1 Q9UNU6 1/20 0.38
MAPK1 P28482 2/20 0.35
CYP2B6 P20813 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8984922 0.83 CYP3A4 (0.40) CYP3A4CYP2C9CYP2C19CYP19A1CYP11B1
SCHEMBL8984919 0.83 CYP3A4 (0.40) CYP3A4CYP2C9CYP2C19CYP19A1CYP11B1
SCHEMBL9198433 0.83 CYP3A4 (0.45) CYP3A4CYP2C9CYP2C19CYP19A1CYP11B1
SCHEMBL8718832 0.83 CYP3A4 (0.48) CYP3A4CYP2C9CYP2C19CYP19A1CYP11B1
SCHEMBL75025 0.83 CYP3A4 (0.48) CYP3A4CYP2C9CYP2C19CYP19A1CYP11B1
SCHEMBL8718853 0.83 CYP3A4 (0.48) CYP3A4CYP2C9CYP2C19CYP19A1CYP11B1
SCHEMBL30121613 0.83 CYP3A4 (0.48) CYP3A4CYP2C9CYP2C19CYP19A1CYP11B1
SCHEMBL9198862 0.82 CYP3A4 (0.43) CYP3A4CYP2C9CYP2C19CYP19A1CYP11B1
Methane SCHEMBL7967605 0.82 CYP3A4 (0.47) CYP3A4CYP2C9CYP2C19CYP19A1CYP11B1
SCHEMBL9203889 0.81 CYP3A4 (0.41) CYP3A4CYP2C9CYP2C19CYP19A1CYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0575425-B1 USE OF OXAZOLO- 2,3-a]ISOINDOLE AND IMIDAZO 2,1-a]ISOINDOLE DERIVATIVES AS ANTIVIRAL DRUGS, AND NEW OXAZOLO 2,3-a]ISOINDOLE DERIVATIVES BOEHRINGER MANNHEIM GMBH (DE) 1995-10-11 EP disclosed
EP-0431968-B1 Oxetane derivatives, their preparation and their use as anti-fungal or fungicidal agents SANKYO CO (JP) 1995-03-15 EP disclosed
EP-0575425-A1 USE OF OXAZOLO- 2,3-a]ISOINDOLE AND IMIDAZO 2,1-a]ISOINDOLE DERIVATIVES AS ANTIVIRAL DRUGS, AND NEW OXAZOLO 2,3-a]ISOINDOLE DERIVATIVES. BOEHRINGER MANNHEIM GMBH (DE) 1993-12-29 EP disclosed
WO-1992016207-A1 USE OF OXAZOLO-[2,3-a]ISOINDOLE AND IMIDAZO[2,1-a]ISOINDOLE DERIVATIVES AS ANTIVIRAL DRUGS, AND NEW OXAZOLO[2,3-a]ISOINDOLE DERIVATIVES BOEHRINGER MANNHEIM GMBH (DE) 1992-10-01 WO disclosed
US-5134152-A 1,2,4-Triazole compounds SANKYO COMPANY, LIMITED (JP) 1992-07-28 US disclosed
EP-0431968-A1 Oxetane derivatives, their preparation and their use as anti-fungal or fungicidal agents Sankyo Company Limited (JP) 1991-06-12 EP disclosed